AU
UK
CA
NZ
IND
US
AstraZeneca (NYSE:AZN) has transformed itself over the past decade into one of the world's leading pharmaceutical companies, powered by a deep and productive pipeline of new medicines, particularly in oncology. With ambitious long-term growth targets and a steady stream of pipeline readouts, the company …
Eli Lilly (NYSE:LLY) has become the defining name in one of the most consequential developments in modern medicine: the rise of GLP-1 drugs for diabetes and weight loss. With its blockbuster treatments Mounjaro and Zepbound driving explosive growth, Lilly has transformed from a respected …
Merck & Co. (NYSE: MRK), known as MSD outside North America, is one of the world’s largest pharmaceutical companies, and the stock remains in focus because of a powerful combination: a blockbuster cancerFranchise, a deep research pipeline, and a looming patent challenge that will …
Novartis (NYSE: NVS) is one of the world’s leading pharmaceutical companies, and the stock remains in the global healthcare spotlight thanks to a sharpened focus on innovative medicines and a deep pipeline of new therapies. Headquartered in Switzerland, Novartis has spent recent years streamlining …
The global market for GLP-1 weight-loss and diabetes therapies is poised to be significantly larger than previously anticipated, according to a fresh assessment by TD Cowen — and the two companies that have dominated the space are expected to maintain their stranglehold well into …
Intuitive Surgical (Nasdaq: ISRG) is the pioneer and dominant force in robotic-assisted surgery, best known for its da Vinci surgical systems. The stock remains in focus because Intuitive sits at the intersection of healthcare and advanced technology, two of the most compelling long-termInvestmentthemes. As …
Danaher (NYSE: DHR) is a leading science and technology company focused on life sciences, diagnostics and biotechnology tools. The stock remains in focus because Danaher provides the instruments, consumables and services that underpin scientific research,Drug Developmentand clinical diagnostics—essential, recurring-demand markets. For investors, DHR offers …
CVS Health (NYSE: CVS) is a diversified healthcare company that combines retail pharmacies, a pharmacy benefit manager, and a majorHealth InsuranceBusiness. The stock remains in focus because CVS is working through a period of strategic challenges and a potential turnaround, as it integrates its …
Eli Lilly has emerged as one of the most influential pharmaceutical companies in the world, driven by itsLeadershipin obesity, diabetes, neuroscience, and immunology. The company's breakthrough therapies have transformed treatment standards while creating one of the strongest growth profiles in the healthcare sector.
Travere Therapeutics has emerged as one of the most compelling growth stories in the biotechnology sector as the company successfully transitions from a development-stage biotech into a commercial rare-diseaseFranchise. Investor confidence has strengthened considerably following the expansion of FILSPARI's commercial opportunity, creating a pathway …
Please wait processing your request...